IL-10 confers protection from mast cell degranulation in a mouse model of allergic conjunctivitis

Experimental Eye Research

Volumn 85, Issue 4, 2007, Pages 575-579

  Bundoc, Virgilio G ^a   Keane Myers, Andrea ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

allergic conjunctivitis; Compound 48 80; mast cell; mouse model

Indexed keywords

COMPOUND 48-80; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 10;

ALLERGIC CONJUNCTIVITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; WILD TYPE;

ANIMALS; CELL DEGRANULATION; CONJUNCTIVITIS, ALLERGIC; DISEASE MODELS, ANIMAL; INTERLEUKIN-10; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 34948883557     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2007.07.005     Document Type: Article

References (34)

1. Allansmith M.R., Baird R.S., Ross R.N., Barney N.P., and Bloch K.J. Ocular anaphylaxis induced in the rat by topical application of compound 48/80. Dose response and time course study. Acta Ophthalmol. Suppl. 192 (1989) 145-153
2. Aridor M., Traub L.M., and Sagi-Eisenberg R. Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins. J. Cell Biol. 111 (1990) 909-917
3. Arock M., Zuany-Amorim C., Singer M., Benhamou M., and Pretolani M. Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol. 26 (1996) 166-170
4. Baltzly R., Buck J.S., DeBeer E.J., and Webb F.J. A family of long-acting depressors. J. Am. Chem. Soc. 71 (1949) 1301-1305
5. Befus A.D., Chin B., Pick J., Evans S., Osborn S., and Forstrom J. Proteinases of rat mast cells. Peritoneal but not intestinal mucosal mast cells express mast cell proteinase 5 and carboxypeptidase A. J. Immunol. 155 (1995) 4406-4411
6. Bouton L.A., Ramirez C.D., Bailey D.P., Yeatman C.F., Yue J., Wright H.V., Domen J., Rosato R.R., Grant S., Fischer-Stenger K., et al. Costimulation with interleukin-4 and interleukin-10 induces mast cell apoptosis and cell-cycle arrest: the role of p53 and the mitochondrion. Exp. Hematol. 32 (2004) 1137-1145
7. Cook E.B., Stahl J.L., Barney N.P., and Graziano F.M. Ocular mast cells. Characterization in normal and disease states. Clin. Rev. Allergy Immunol. 20 (2001) 243-268
8. Ghildyal N., Friend D.S., Nicodemus C.F., Austen K.F., and Stevens R.L. Reversible expression of mouse mast cell protease 2 mRNA and protein in cultured mast cells exposed to IL-10. J. Immunol. 151 (1993) 3206-3214
9. Gillespie S.R., DeMartino R.R., Zhu J., Chong H.J., Ramirez C., Shelburne C.P., Bouton L.A., Bailey D.P., Gharse A., Mirmonsef P., et al. IL-10 inhibits FcεRI expression in mouse mast cells. J. Immunol. 172 (2004) 3181-3188
10. Haddad J.J., Saade N.E., and Safieh-Garabedian B. Interleukin-10 and the regulation of mitogen-activated protein kinases: are these signalling modules targets for the anti-inflammatory action of this cytokine?. Cell Signal 15 (2003) 255-267
11. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., and Locksley R.M. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169 (1989) 59-72
12. Irani A.M., Butrus S.I., Tabbara K.F., and Schwartz L.B. Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis. J. Allergy Clin. Immunol. 86 (1990) 34-40
13. Irani A.M., Bradford T.R., Kepley C.L., Schechter N.M., and Schwartz L.B. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J. Histochem. Cytochem. 37 (1989) 1509-1515
14. Jacobs P., Radzioch D., and Stevenson M.M. A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect. Immun. 64 (1996) 535-541
15. Johnson A.R., and Moran N.C. Release of histamine from rat mast cells: a comparison of the effects of 48-80 and two antigen systems. Fed. Proc. 28 (1969) 1716-1720
16. Karimi K., Redegeld F.A., Heijdra B., and Nijkamp F.P. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro. Exp. Hematol. 27 (1999) 654-662
17. Kitagaki K., Businga T.R., Racila D., Elliott D.E., Weinstock J.V., and Kline J.N. Intestinal helminths protect in a murine model of asthma. J. Immunol. 177 (2006) 1628-1635
18. Ko S.M., Kim M.K., and Kim J.C. The role of nitric oxide in experimental allergic conjunctivitis. Cornea 19 (2000) 84-91
19. Lagunoff D., Martin T.W., and Read G. Agents that release histamine from mast cells. Annu. Rev. Pharmacol. Toxicol. 23 (1983) 331-351
20. Li Q., Luyo D., Hikita N., Whitcup S.M., and Chan C.C. Compound 48/80-induced conjunctivitis in the mouse: kinetics, susceptibility, and mechanism. Int. Arch. Allergy Immunol. 109 (1996) 277-285
21. Meijer F., Van Delft J.L., Garrelds I.M., Van Haeringen N.J., and Kijlstra A. Nitric oxide plays a role as a mediator of conjunctival edema in experimental allergic conjunctivitis. Exp. Eye Res. 62 (1996) 359-365
22. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol. Rev. 77 (1997) 1033-1079
23. Mirmonsef P., Shelburne C.P., Fitzhugh Yeatman II C., Chong H.J., and Ryan J.J. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase. J. Immunol. 163 (1999) 2530-2539
24. Mousli M., Bronner C., Landry Y., Bockaert J., and Rouot B. Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett. 259 (1990) 260-262
25. Paton W.D. Compound 48/80: a potent histamine liberator. Br. J. Pharmacol. Chemother. 6 (1951) 499-508
26. Razin E., Mencia-Huerta J.M., Stevens R.L., Lewis R.A., Liu F.T., Corey E., and Austen K.F. IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells. J. Exp. Med. 157 (1983) 189-201
27. Royer B., Varadaradjalou S., Saas P., Guillosson J.J., Kantelip J.P., and Arock M. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin. Exp. Allergy 31 (2001) 694-704
28. Sagi-Eisenberg R. The molecular mechanisms of allergic diseases: immunoglobulin E dependent and independent signaling pathways converge in eliciting the release of arachidonic acid metabolites. Isr. Med. Assoc. J. 4 (2002) 963-966
29. Schwartz L.B., Austen K.F., and Wasserman S.I. Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J. Immunol. 123 (1979) 1445-1450
30. Shibuya K., Robinson D., Zonin F., Hartley S.B., Macatonia S.E., Somoza C., Hunter C.A., Murphy K.M., and O'Garra A. IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J. Immunol. 160 (1998) 1708-1716
31. Stahl J.L., and Barney N.P. Ocular allergic disease. Curr. Opin. Allergy Clin. Immunol. 4 (2004) 455-459
32. Thompson-Snipes L., Dhar V., Bond M.W., Mosmann T.R., Moore K.W., and Rennick D.M. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J. Exp. Med. 173 (1991) 507-510
33. Tiligada E., Aslanis D., Delitheos A., and Varonos D. Changes in histamine content following pharmacologically-induced mast cell degranulation in the rat conjunctiva. Pharmacol. Res. 41 (2000) 667-670
34. Toda S., Kimura M., and Tohya K. Strain differences in histamine release from mouse peritoneal mast cells induced by compound 48/80 or A23187. Jikken Dobutsu 38 (1989) 135-137